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Abstract 
Padded socks to protect the at-risk diabetic foot have been available for a number of years. 
However, the evidence base to support their use is not well known. We aimed to undertake a 
systematic review of padded socks for people with diabetes. Additionally, a narrative analysis 
of knitted stitch structures, yarn and fibres used together with the proposed benefits fibre 
properties may add to the sock. Assessment of the methodological quality was undertaken 
using a quality tool to assess non-randomised trials. From the 81 articles identified only seven 
met the inclusion criteria. The evidence to support to use of padded socks is limited. There is 
a suggestion these simple-to-use interventions could be of value, particularly in terms of 
plantar pressure reduction. However, the range of methods used and limited methodological 
quality limits direct comparison between studies. The socks were generally of a sophisticated 
design with complex use of knit patterns and yarn content. This systematic review provides 
limited support for the use of padded socks in the diabetic population to protect vulnerable 
feet. More high quality studies are needed; including qualitative components of sock wear 
and sock design, prospective randomized controlled trials and analysis of the cost-
effectiveness of protective socks as a non-surgical intervention. 
Keywords 
Diabetes, Diabetic foot, Offloading, Footwear 
Introduction 
Diabetes mellitus, particularly the mature onset or type-two variation (T2DM) is a major 
health concern world-wide [1-3]. T2DM is a cause of significant co-morbidity and is 
predicted to further increase over the next 20 years contributing to a greater diabetes-related 
burden [1,4-6]. Some 15%-25% of people with diabetes will suffer a foot ulcer [7,8] and limb 
amputation is preceded by foot ulceration in 85% of cases [9]. More worryingly it is 
suggested that some 80% of amputations are preventable [10]. The aetiology of foot ulcers is 
complex and has been extensively reviewed [11-14]. Complications (including vascular 
disease, peripheral neuropathy, increased mechanical stress and Charcot neuroarthropathy) 
greatly increase the incidence of lower limb amputations [14-17]. However, the nature of 
diabetes means even those at low risk can develop foot complications [18], particularly in the 
presence of poor glycaemic control and/or a lack of regular foot assessment. Foot 
complications negatively impact individuals’ quality of life and their ability to be productive 
members of society and these complex pathologies are a considerable health system burden 
[19-21]. 
A range of non-surgical approaches can be used to prevent the foot complications seen in 
diabetes including education, self-care/self-monitoring of feet, appropriate skin and nail care, 
wearing supportive footwear and protective socks, as well as formal podiatric assessment and 
treatment [22-24]. From a commercial perspective a vast range of protective socks are 
commercially available (Additional file 1). Recent studies in diabetic foot ulcer prevention 
have reported on foot orthoses and footwear to reduce foot pressure [25,26]. A systematic 
review [27] considered ‘socks for people with diabetes’ but did not present any formal 
scoring, yet determined results for this type of hosiery were inconclusive. A recent Cochrane 
review appraised off-loading strategies, but did not include protective socks [28]. Therefore, 
we sought to undertake a systematic review of protective socks for people with diabetes and 
included a narrative analysis of these socks, which included an analysis of the knitted stitch 
structure and yarn/fibre type. 
Review 
Methods 
This systematic review was undertaken according to the guidelines provided by the Cochrane 
Collaboration [29] and the PRISMA group [30]. 
Search and selection process 
To obtain all articles relating to the use of socks for people with diabetes an extensive 
literature search was designed jointly by the lead author (SO) and an experienced librarian 
(AS) performed across several databases EBSCO (Biomedical reference collection, Cinhal, 
Health business elite, Health source, Medline, Sport discuss) SCOPUS, AMED, Cochrane 
and PEDro. Databases were searched from 1985 – 2014, as socks for people with diabetes 
were not available prior to 1985. Further searches of manufacturer’s websites were also 
conducted. 
Publications were identified through a search that used the following MeSh terms: (diabet* 
AND sock) OR (diabet* AND socks) OR (diabet* AND hosiery) OR (diabet* AND padded). 
Articles were limited to “humans” and “English”. Inclusion criteria comprised articles 
reporting any type of clinical trial design, including people with diabetes reporting the use of 
socks for people with diabetes. Articles were initially excluded if they did not report diabetes; 
did not focus on socks for people with diabetes as a mechanism for foot protection reduction, 
(for example articles reporting the use of hosiery to control oedema). Articles relating to non-
diabetic groups, for example, healthy populations or sports were also excluded. Owing to a 
paucity of high quality research, studies were included if they were of level four or above 
[31] and in English language. Reviews, editorials, letters and single case histories were 
excluded. The selection process was performed on the titles of articles, the abstract then on 
full text (Figure 1). 
Figure 1 PRISMA diagram to show selection of publications. 
General data extraction 
Publications were evaluated based on the full text article and reviewers were not blinded to 
the journal title or authors. Information was extracted based on year of publication, study 
design and number of participants. Demographic data such as gender, age, duration of 
diabetes, disease features and length of follow-up was also recorded. Publications were 
reviewed with the use of a tool developed by Downs & Black [32]. While the Cochrane 
Collaboration [29] does not recommend a specific tool for non-randomised clinical trials, this 
instrument has been widely used for non-pharmacological trials and provides a score between 
0-32 across 27 questions: a higher score representing robust, high quality methodology. The 
tool is easy to complete with high internal consistency, test-retest and inter-rater reliability 
reported to be good by the authors [32]. The checklist covers study quality (10 items), 
external validity (3 items), bias (7 items), confounding and selection bias (6 items) and the 
power of the study (1 item) [33]. 
Statistical Analysis 
Analysis was mainly descriptive based on an analysis of the narrative provided by studies, i.e. 
the extent to which plantar pressures were reduced; together with the Downs and Black score 
for each article. In this review four questions (7, 15, 16 and 25) were omitted from the Downs 
& Black tool as these were not applicable to any of the trials being reviewed. Each score is 
therefore expressed as a percentage to permit ease of comparison. 
Description of publications 
A total of 81 articles were retrieved, but we identified only seven prospective studies [34-40] 
that met the inclusion criteria. A further five papers [41-45] considered the role of protective 
socks in other populations (e.g. athletes’ or rheumatoid arthritis). While these findings may 
be transferrable to the diabetic population, they were excluded from the review. From the 
additional 70 articles that were excluded, many were duplicates (n = 23). Others were 
industry reports highlighting new product developments (n = 12), but not providing any 
empirical evidence to support the product (Figure 1). A further 18 papers consisted of 
education and/or continuing professional development articles for health professionals 
highlighting the need to protect the ‘at risk’ diabetic foot. Of the seven studies included, three 
were case series, three cross sectional designs and one single blind RCT. The main 
characteristics of the studies reviewed are presented in Table 1. The mean quality score was 
39% (SD 20, range 17-78%) - details in Table 2. 
Table 1 Overview of studies reviewed 
Study Demographic data Inclusion criteria (in addition 
to diabetes) 
Findings 
Blackwell et 
al. [34] 
No of subjects 21 Diabetes with foot complaints, no 
active ulceration 
Plantar pressure assessed with Parotec system 
Gender 10 M : 11 F 
Mean age (range) 
57.4 (20-83) 
No significant difference between JBOST diabetic sock, normal sock 
or barefoot 
Diabetes duration 
Not stated 
Veves et al. 
[35] 
No of subjects 27 High plantar pressures (>10 
kg/cm2) 
Plantar pressure assessed with optical pedobarograph 
Gender 15 M: 2 F Neuropathy (diminished nerve 
conduction & vibration 
perception) 
Experimental socks [Thorlo] provided significant pressure reduction 
compared with pts own socks or barefoot (both p < 0.001) Mean age (range) 54 
(26-74) 
Diabetes duration 
not stated 
Able walk unaided, no PVD, no 
ulcer history 
Veves et al. 
[36] 
Gender not stated Neuropathy (diminished 
vibration perception & absent 
ankle reflex) 
Plantar pressure assessed with optical pedobarograph 
Experimental group 
(n = 10) 
mean age (range) 
51.3 (27-65) 
Duration of diabetes 
not stated 
Significant reduction in pressure of experimental socks [Thorlo] 
compared with padded sports socks & barefoot (all p < 0.001). 
Pressure reduction maintained by experimental socks at 3 & 6 
months. 
Control group n = 
16 
Mean age (range) 
55.8 (33-70) 
Garrow et al. 
[37] 
No of subjects 19 Neuropathy (neuropathy 
disability score >5 or diminished 
vibration perception ≥25). 
Plantar pressure assessed with F-scan system 
Gender 15 M:4 F 
Mean age (range) 
65.5 (39-80) 
Ulcer-free at recruitment Preventative Foot Care Diabetic socks provided significant increase 
in foot contact area (p < 0.01), a reduction total pressure (p < 0.01). 
Diabetes duration 
median 20 yrs 
High plantar pressure (≥6 
kg/cm2). 
Murray et al. 
[38] 
No of subjects 86 Neuropathy (diminished pressure 
or vibration perception) 
Questionnaire based satisfaction survey over 6 month period using 
Thorlo socks Gender 69 M :17 F 
Mean age (range) 63 
(34-85) 
No active ulceration Socks reported good/very good by 86%, average by 12% & poor by 
3%. 
Mean diabetes 
(range) 16 (1–45 yrs 
84% reported continue sock use at 3 & 6 months 
Banchellini et 
al. [39] 
No of subjects 30 Peripheral neuropathy (ADA 
criteria) 
Skin parameters tested: 
Gender not stated Hydration (hydration score) Hardness (Durometer) 
Group A (Difoprev) 
socks 
Anhidrosis (Clinical features & 
Neuropad test) 
Moisture loss (Scalar moisture checker) 
Mean age 59.6 
(SD13.8) 
Water loss (TEWL vapometer) 
Duration diabetes 
16.1 (SD9) 
No active ulceration, ABPI >0.9, 
Serum creatinine >2 mg/dL 
All skin parmeters improved over 6 week trial (Difoprev) socks & 
normal socks 
Group B (no active 
sock ingredient) 
Mean age 61.4 
(SD15.5) 
Skin hydration p < 0.01 Skin hardness p <0.05 
Duration diabetes 
15.7 (SD6.9) 
No systemic skin disease, no B-
blocker therapy 
Controls (normal 
socks) 
Skin moisture loss p < 0.01 Skin water loss p < 0.01 
Mean age 60.5 
(SD11.4) 
Yick et al. 
[40] 
No of subjects 4 No inclusion criteria stated Plantar pressure (Pedar system) 
Gender not stated Skin temperature & humidity (system not stated) 
Age not stated Socks tested not stated 
Diabetes duration 
not stated 
Considerable pressure reduction stated but not per sock type 
Thermal properties are stated but not compared between socks or post 
sock wear 
Table 2 Description of scoring based on Downs & Black criteria 
Study Is 
the 
aim 
of 
the 
stud
y 
clea
r? 
Are the 
main 
outcom
es 
clearly 
describ
ed? 
Are 
characteri
stics of 
patients 
included 
clearly 
described? 
Are the 
interventi
ons 
clearly 
described
? 
Are co-
founder
s 
clearly 
describ
ed? 
Are the 
main 
findings 
clearly 
describ
ed? 
Have 
advers
e 
events 
been 
reporte
d? 
Are 
subjects 
lost to 
follow up 
characteri
stics 
reported? 
Are 
actual 
Probabi
lity 
values 
reporte
d? 
Were 
subjects 
invited 
representa
tive of 
population 
Subjects 
who 
participat
ed 
representa
tive of 
population
? 
Were staff, 
places & 
facilities 
representat
ive? 
Was 
there 
an 
attem
pt to 
blind 
study 
subjec
ts? 
Were 
analyses 
adjusted 
for 
different 
lengths of 
follow-up 
between 
interventi
ons? 
Were 
appropri
ate 
Statistic
al tests 
used? 
Was 
complian
ce with 
interventi
ons 
reliable? 
Were 
main 
outco
me 
measu
res 
accura
te and 
reliabl
e? 
Were 
cases/cont
rols 
recruited 
from 
same 
populatio
n? 
Were 
cases/cont
rols 
recruited 
over same 
time? 
Were 
subjects 
randomi
zed to 
intervent
ion 
groups? 
Was 
randomi
zed 
intervent
ion 
conceale
d form 
subjects 
& 
clinician
s? 
Are 
analys
es 
adjust
ed for 
lost to 
follow 
up 
subjec
ts 
Study 
have 
sufficie
nt 
power 
to 
detect 
clinical
ly 
import
ant 
effect? 
Total 
score 
(%) 
based 
on 23 
items 
Veves et 
al. [37] 
X X X X O O X U O U X X O U X X X U U U U U O 10 
(43.5 
%) 
Veves et 
al. [38] 
X X X X O X X U O U U X O O X X X U U U U U O 10 
(43.5
%) 
Murray 
et al. 
[40] 
X O X X X O X U O U U U O U U X U U U U U U U 6 
(26.1
%) 
Blackw
ell et al. 
[36] 
X O O X O O O O O U U U O U X X X U U U U O O 5 
(21.8
%) 
Garrow 
et al. 
[39] 
X X X X X X U O O U U X O U U U X U U X O O U 9 
(39.2 
%) 
Banchel
lini et 
al. [41] 
X X X X X X X U O X X X X X X X X X X X O U U 18 
(78.3
%) 
Yick et 
al. [42] 
X X O X O O O U O U U U O O U U X U U U U U O 4 
(17.4 
%) 
X = yes, O = no, U = unable to tell. 
Questions omitted: 7 - no trials reported the random variability for their main outcomes, 15 - none of the studies were double-blind, 16 - there was no evidence of data dredging, 25 - cofounding variables were not adjusted for throughout. 
Plantar foot pressure 
Five studies [34-38,40] used peak plantar pressure as the primary outcome measure. A 
variety of protective socks were included. Additionally, most studies also included a control 
element with subjects using their own socks or standard shop-bought socks together with 
barefoot pressure measurements as a true control condition. Three studies [35-37] reported 
padded socks provided a significant reduction in peak plantar pressure. They suggest that in 
conjunction with wearing proper footwear/orthoses, padded socks could help prevent foot 
ulcer formation. However, one study [34] reported an increase in peak plantar pressure with 
padded socks. One study reported a follow-up period [36] and a significant reduction in peak 
plantar pressure was maintained at 6 months, although this reduction was not as great as was 
seen at baseline. 
Plantar contact area 
One study [40] reported plantar contact area as an outcome and reported a significantly 
greater contact area with socks for people with diabetes compared with ordinary shop-bought 
socks. These authors demonstrated an increase in maximum foot contact area of 11 cm2 when 
subjects wore the protective socks, accompanied by a 9% reduction in total foot pressure. 
Similar results were observed at the forefoot, a 14% increase in contact area and 10% 
reduction in peak forefoot pressure. 
Patient satisfaction 
One study used a survey design approach to quantify how satisfied subjects were with socks 
designed to reduce pressure over a 6-month period [41]. The results were positive; with 85% 
reporting high satisfaction, and 84% of participants reported they wished to continue wearing 
the socks after the trial. 
Skin moisture and temperature 
Banchellini et al. [39] reported in a 6-week randomised trial into a new nanotechnology 
impregnated sock design intended to increase skin moisture content. The sock (Difoprev 
system, LVM technologies Italy) consisted of a synthetic polyammide fibre loaded with 
microcapsules of an emollient agent. Additionally, Yick et al. [40] noted an increase in skin 
temperature and humidity with protective socks in a sample of two subjects with diabetes. 
From this review there is weak evidence that protective socks may reduce foot pressures and 
provide additional protection for the at-risk foot in diabetes. There are four domains (plantar 
pressure, plantar contact area, satisfaction and skin moisture) that reflect relevant clinical 
outcomes and are reported in research articles over 25 years. However, in spite of 
sophisticated sock design and material usage employed by manufacturers, studies received 
low scores using the Downs and Black instrument. The majority of studies compared very 
small populations and were not adequately powered. This together with limitations in the 
overall design (e.g. lack of randomization, blinding of participants and/or clinicians) also 
contributed to low scores. While it is difficult to blind clinicians working in healthcare 
settings, the guidance offered by Boultron et al. [46] and Cook [47] are essential as a lack of 
non-blinded assessors can cause a high risk of observer bias [48]. In most studies some 
attempt was made to identify participants with diabetes who would benefit more from 
protective socks (i.e. those with higher plantar pressures and loss of protective sensation), 
which might also suggest greater improvements would be reported. However, not all articles 
controlled for the complications commonly seen in diabetes (e.g. vascular disease, current 
foot ulceration or previous amputation). While this may represent the heterogeneous nature of 
foot complaints seen in diabetes, equally there were no clear attempts to include adequate 
numbers of subjects with these complications to represent the heterogeneous nature of foot 
complaints seen in the diabetic population. Moreover, the contention of many articles was 
that reducing foot pressure would prevent foot ulceration. However, the incidence of foot 
ulceration was not a primary outcome measure and not always stated as an adverse event. 
Plantar pressures have long been recommended as a key outcome measure to identify those at 
risk of foot ulceration [17,49]. Notably, up to three-quarters of foot ulcers are over the 
metatarsal head region [50] – often an area of high pressure. Ulbrect et al. [26] report that 
peak barefoot plantar pressure is the key determinant when manufacturing bespoke orthoses 
to off-load pressure. A significant reduction in plantar pressure was reported by three studies 
while using protective socks [35-37]. However, considerable variations between peak plantar 
pressure values have also been reported for those with and without foot ulcers [26,51,52]. 
These differences may be due to a number of factors, including the protocol and equipment 
used. In the articles we reviewed, research protocols were often not clearly described. That 
said, many were published prior to the development of guidelines for plantar pressure studies 
[53]. Additionally, footwear is often key a therapeutic intervention [27,54] so controlling for, 
or standardizing, footwear should also be a consideration when designing research protocols 
to test protective socks. Foot structure, biomechanics and tissue glycation may have a marked 
effect on plantar pressure variables [55-57] and these variables should also be considered 
either as part of the exclusion criteria or as potential confounders when assessing the impact 
of protective socks on plantar pressures. 
Satisfaction and concordance with interventions is a key area for research, as patients are 
unlikely to continue to wear socks they are unhappy with or find uncomfortable. Only one 
study [38] addressed this important aspect of practice, but the instrument used to determine 
satisfaction was not provided, making an adequate assessment of its appropriateness, 
responsiveness and reliability difficult. Any changes in clinical outcomes (e.g. a reduction in 
plantar pressure) that may have occurred during the study period was not reported. 
From the narrative analysis of articles and website data, all socks reviewed were knitted using 
a weft knit method with a variety of yarns (Additional file 1). We noted sophisticated sock 
designs that included the use of pile fabric knit structures over areas requiring extra padding 
to reduce pressure, rib knit structures used to provide compression and support structure over 
the ankle and mesh or tuck knit structures allowing for free ventilation where less protection 
and greater flexibility is needed. Bertaux et al. [58] reported significant correlations between 
physiological and sensory parameters as well as between fabric friction and perceived 
comfort in eleven subjects wearing sports socks. This highlights that ‘comfortable’ socks 
provide lower friction coefficients and hence reduce the potential for skin damage. 
Maximising protection and reducing friction at the foot/sock interface is thought to be key for 
preventing lesions in the at-risk diabetic foot [59]. However, parameters such as shear and 
temperature were typically not comprehensively studied in the articles we reviewed. While 
not a padded sock per se, the Difoprev system reported by Banchelline et al. [39] provided a 
significant increase in skin hydration. A decrease in moisture loss, water loss and hardness is 
of value to people with insensate feet, where autonomic neuropathy in particular is known to 
cause excessive dryness and is a risk factor for foot ulceration [13,60]. 
This paper represents the first review to combine a systematic review on a topic that has not 
been previously addressed, together with a narrative analysis of the key intervention. There 
are some limitations to consider. Ideally a meta-analysis would be conducted in conjunction 
with this systematic review. However, this was not possible as the studies using plantar 
pressure analysis (the primary outcome in the majority of studies) were conducted with 
various systems to measure foot pressure. This results in different spatial and temporal 
resolutions, data extraction and management approaches. Additionally, the main plantar 
pressure variable was reported differently throughout. These factors make comparisons 
between trials difficult and not conducive to further statistical analysis. 
Conclusion 
Altering the socks people with diabetes wear could provide a simple, cosmetically acceptable, 
and potentially cost-effective method of protecting the at-risk foot in diabetes. However, the 
previous studies of protective socks were often poorly controlled, underpowered and did not 
justify the primary outcomes reported. Consequently, there are opportunities for further 
research, including qualitative components of sock wear and sock design, together with 
randomized controlled trials and analysis of cost-effectiveness. 
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